# Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

> **NCT01053104** · — · COMPLETED · sponsor: **University of Oxford** · enrollment: 26 (actual)

## Conditions studied

- Metastatic Colorectal Cancer
- Metastatic Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01053104
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-12
- **Final completion:** 2011-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-07-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053104, "Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01053104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*